Tilray Medical Welcomes a Luxembourg Government Delegation to Its European Campus in Portugal

Published: June 24, 2022

Tilray Medical Welcomes a Luxembourg Government Delegation to Its European Campus in Portugal

Tilray Brands Inc., a global leader in cannabis lifestyle and consumer goods , which inspires and empowers the global community to live their best life, welcomes the delegation from the Luxembourg Ministry of Health to the company’s European campus in Cantanhede, Portugal. Tilray’s EU-GMP certified medical cannabis cultivation and manufacturing facility in Portugal provides patients in Luxembourg and across Europe, where legally permitted, safe and reliable access to high-quality medical cannabis.

The visit was organized to give the Luxembourg delegation a first-hand look at Tilray’s EU-GMP operations in Portugal, the first medical cannabis site in Europe. The delegation included:

  • Paulette Lenert, Deputy Prime Minister and Minister of Health in Luxembourg
  • HE Conrad Bruch, Ambassador of Luxembourg to Portugal
  • Alain Origer, National Drugs Coordinator
  • Laura Valli, International Affairs Coordinators
  • Bob Lessel, Department of Social Affairs and Health
  • Sven Back, Department of Narcotics and Medicinal Cannabis


Sascha Mielcarek, Tilray’s Managing Director in Europe, said: “We are honored to host the delegation from the Luxembourg Ministry of Health at our state-of-the-art cannabis facility in Cantanhede, Portugal. Demand for cannabis legalization in Europe is growing rapidly. We take incredible pride in providing patients in Luxembourg and around the world with high-quality medical cannabis products they can rely on, in the formats they prefer.”

Tilray has a strong track record as a company dedicated to producing the highest quality cannabis products for consumers and patients in need around the world. It was the first company to successfully export medicinal cannabis from North America and import medicinal cannabis products to the EU in 2016.

About Tilray Medical
Tilray Medical’s mission is to transform lives and advance the dignity of patients in need through safe and reliable access to a global portfolio of medical cannabis brands including Tilray, Aphria, Broken Coast and Symbios. Tilray has seen steady growth from being one of the first companies to be approved as a licensed medical cannabis producer in Canada to building the first GMP certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the largest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers and governments in 20 countries and on five continents. For more information about Tilray Medical, visitTilray Medical Canada , Tilray Medical Australia , Tilray Medical Australia-New Zealand and Tilray Medical Europe .

About Tilray Brands
Tilray Brands, Inc. is a global leader in cannabis lifestyle and consumer goods with operations in Canada, the United States, Europe, Australia and Latin America, making people’s lives better changes. Tilray Brands fulfills this mission by inspiring and empowering the global community to live their best life and by providing access to products that meet the needs of the mind, body and spirit and evoke well-being. Patients and consumers trust Tilray Brands to deliver a cultured experience and health and wellness through quality, differentiated brands and innovative products. As a pioneer in cannabis research,
For more information on how we are opening a world of wellness, visit www.Tilray.com .